Recent Study: Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012

Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012

Summary

GlobalData's "Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides detailed information on Partnerships, Licensing Agreements, M&As, Equity/Debt Offerings, Private Equity and Venture Financing transactions registered in the pharmaceutical and healthcare industry in 2012. The report presents detailed comparative data on the number of deals and their value in the past five years categorized into deal types, segments, and geographies. Additionally, the report provides information on the top venture capital and advisory firms in the pharmaceutical and healthcare industry.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/585857_pharmaceutical_healthcare_annual_deals_analysis.aspx?afid=303
------------------------------------------------------------

Data presented in this report is derived from GlobalData's proprietary in-house deals database and primary and secondary research.

Scope

* Analysis of the market trends for the pharmaceutical industry in the global arena.
* Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
* Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
* Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
* Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
* Analysis of partnership and licensing deals based on clinical stage of development of products.
* Summary of the pharmaceutical deals globally in the last five years.
* Information on the top deals happened in the pharmaceutical industry.
* Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
* League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

* Enhance your decision making capability in a more rapid and time sensitive manner.
* Find out the major deal performing segments for investments in your industry.
* Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2012
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2012
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - February 2012
- Partnerships, Licensing, Investments and M&A Deals and Trends For August 2012 In Pharmaceuticals